Impedimed

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Company

Indicator

Code Company Date Close Change Indicator Value Signal

Trading Performance

Money Flow Index

Score

-2.25

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
SHORT 2 244.5 0.50% 1.00% 112.7% -55.6% 57.1%
LONG 2 70.5 0.00% 0.00% 0.0% -42.0% -84.1%

Summary

Technical Analysis

Impedimed (IPD.AX)


Indicator:

MONEY FLOW INDEX


Last Signal:

NEUTRAL


Trading: NO POSITION
Signal Strength: MEDIUM


Money Flow Index (MFI) is a volume-based indicator it could be used in technical analysis to measure the strength of money flow in and out of a security index and market. The principle of MFI calculation is a comparison of positive money flow to negative money flow. MFI is also known as volume-weighted RSI. MFI starts with the typical price for each period. The same as RSI the MFI scale is between 0 and 100.

Calculation: Money Flow Index (MFI):
1) Typical Price = (High + Low + Close)/3;
2) Raw Money Flow = Typical Price x Volume;
3) Money Flow Ratio = (14-period Positive Money Flow)/(14-period Negative Money Flow);
4) Money Flow Index = 100 - 100/(1 + Money Flow Ratio)


PROFILE: Impedimed (IPD.AX)


Stock Exchange: ASX
Company: Impedimed
Ticker Codes: | IPD.AX | ASX:IPD |

About Impedimed (ASX:IPD):

ImpediMed Limited, together with its subsidiaries, engages in the development, manufacture, and sale of bioimpedance devices and consumables in Australia, North America, Europe, and internationally. The company operates through Medical and Test & Measurement segments. It offers L-Dex U400, a technology that utilizes the characteristics of frequency dependent current flow to quantify changes in extracellular fluid in the patient's limb; and SFB7, a tetra polar bioimpedance spectroscopy device that scans various frequencies for the estimation of body composition in healthy individuals. The company also provides DF50, a single frequency body composition analysis in healthy individuals; and ImpediVET, a bioimpedance spectroscopy technology for use in veterinary applications. Its products are used in a range of applications, such as in the assessment and monitoring of secondary lymphedema, as well as monitoring of body composition and hydration. In addition, the company is involved in the supply of power precision testing and measuring equipment. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.

Top 10:

Money Flow Index

Download
Company Close Change(%) Volume Value Signal
SIQ Smartgroup 11 21.7 2,435,618 71.71 NEUTRAL
URF Us Masters Residential Property Fund 0.85 18.1 636,687 53.73 NEUTRAL
GSW Getswift 0.28 12 1,005,626 48.64 NEUTRAL
LLC Lend Lease Corporation 15.01 10.9 5,153,464 43.57 NEUTRAL
BPT Beach Petroleum 2 10.8 15,230,683 41.72 NEUTRAL
JIN Jin 18.86 10.2 1,202,465 43.28 NEUTRAL
IMD Imdex 1.3 7.9 4,121,418 40.92 NEUTRAL
IRD Iron Road 0.06 6.9 10,000 46.1 NEUTRAL
KGN Kogan 5.24 6.5 445,750 53.79 NEUTRAL
APX Appen 24.52 6.4 826,568 29.67 NEUTRAL